Pharmacytimes: Condition Center: Atrial Fibrillation http://www.pharmacytimes.com/condition-resources/afib/condition-rss Atrial Fibrillation en-us Wed, 26 Apr 2017 03:25:29 UTC Wed, 26 Apr 2017 03:25:29 UTC Researchers Discover Potential Marker for Ablation Success in AF Patients http://www.pharmacytimes.com/resource-centers/afib/researchers-discover-potential-marker-for-ablation-success-in-af-patients A recently-presented study suggests new markers to determine whether atrial fibrillation (AF) is likely to recur after ablation.&nbsp; 10:20 AM, Thu April 6, 2017 Dr. William Borden on Advice for Adjusting to MACRA http://www.pharmacytimes.com/resource-centers/afib/dr-william-borden-on-advice-for-adjusting-to-macra The Quality Payment Program from CMS, including the Medicare Access and CHIP Reauthorization Act, represents a shift toward focusing on quality measures, but there are resources available to help clinicians adjust to these changes, explained William Borden, MD, FACC, FAHA, associate professor of medicine and director of healthcare delivery transformation at the George Washington University. &nbsp; 5:10 PM, Thu March 30, 2017 Dr. Seth J. Baum on the Patient's Role in Getting PCSK9 Inhibitors Approved by Payers http://www.pharmacytimes.com/resource-centers/afib/dr-seth-j-baum-on-the-patients-role-in-getting-pcsk9-inhibitors-approved-by-payers It remains unclear why insurers approve some patients for PCSK9 inhibitors while denying others with similar clinical characteristics, according to Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, president of the American Society for Preventive Cardiology, who presented an abstract on the subject at the American College of Cardiology 66th Scientific Session.&nbsp; 5:08 PM, Sat March 25, 2017 Challenges Noted in Filling PCSK9 Prescriptions, Confirming Cardiologists' Complaints http://www.pharmacytimes.com/resource-centers/afib/challenges-noted-in-filling-pcsk9-prescriptions-confirming-cardiologists-complaints- Leading cardiologists at ACC said it is not easy to get their patients access to evolocumab. 3:58 PM, Tue March 21, 2017 Low-Dose Xarelto Bests Aspirin for Preventing Life-Threatening Blood Clots http://www.pharmacytimes.com/resource-centers/afib/lowdose-xarelto-bests-aspirin-for-preventing-lifethreatening-blood-clots- Research is underway to determine the cost-effectiveness of managing VTE patients with rivaroxaban.&nbsp; 4:19 PM, Mon March 20, 2017 ED Drugs Safe After Heart Attacks http://www.pharmacytimes.com/resource-centers/afib/ed-drugs-safe-after-heart-attacks- A study from Sweden has found that phosphodiesterase-5 (PDE-5) inhibitors, prescribed to men for erectile dysfunction, are good for the heart in more ways than previously thought. 4:25 PM, Sun March 19, 2017 Does Aggressive Blood Pressure Treatment Reduce Afib Recurrence? http://www.pharmacytimes.com/resource-centers/afib/does-aggressive-blood-pressure-treatment-reduce-afib-recurrence Atrial fibrillation (AF) recurrence does not appear to be affected by aggressive blood pressure lowering treatments.&nbsp; 8:00 AM, Fri March 10, 2017 Acetaminophen and Warfarin: The Forgotten Interaction http://www.pharmacytimes.com/contributor/thomas-szymanski-pharmd-candidate-2017/2017/02/acetaminophen-and-warfarin-the-forgotten-interaction Up to 18% of patients taking warfarin also take acetaminophen, but clinicians may not recognize the potential interaction between the two medications. 12:01 AM, Mon February 27, 2017 Reduced Dose NOACs Compared with Warfarin for Afib Treatment http://www.pharmacytimes.com/resource-centers/afib/reduced-dose-noacs-compared-with-warfarin-for-afib-treatment Reduced doses of non-vitamin K antagonist oral anticoagulants (NOACs) did not appear to show significant outcome differences in terms of stroke and bleeding rates compared with warfarin in patients with atrial fibrillation (AF).&nbsp; 9:00 AM, Wed February 22, 2017 AF Risk Increases with More Pregnancies? http://www.pharmacytimes.com/resource-centers/afib/af-risk-increases-with-more-pregnancies One study linked multiple pregnancies increases a woman&rsquo;s risk of developing&nbsp;atrial fibrillation&nbsp;later in life, and another investigated the associated between premature delivery and cardiovascular disease.<br /> &nbsp; 1:11 PM, Sun February 12, 2017 Hospitalizations Related to Afib Rise, But Mortality Rates Fall http://www.pharmacytimes.com/resource-centers/afib/hospitalizations-related-to-afib-rise-but-mortality-rates-fall Patients with atrial fibrillation are hospitalized more frequently than in the past, but survival rates are getting better, concludes a study. 9:57 AM, Fri February 3, 2017 Thromboembolic Risk in AF and Diabetes May Be Insulin Related http://www.pharmacytimes.com/resource-centers/afib/thromboembolic-risk-in-af-and-diabetes-may-be-insulin-related Individuals with diabetes and atrial fibrillation (AF) are often at risk for thromboembolic events, but a new study explores the role that insulin plays in elevating rates of thromboembolic incidents.&nbsp; 8:00 AM, Fri January 27, 2017 Increased Risk of Complications with Left Ventricular Ablations? http://www.pharmacytimes.com/resource-centers/afib/increased-risk-of-complications-with-left-ventricular-ablations Seven of the 12 patients (58%) who underwent LV ablation experienced 16 brain embolisms combined, compared to zero patients who underwent the RV ablation. 2:20 PM, Thu January 26, 2017 Good Results with Catheter Ablation in Afib http://www.pharmacytimes.com/resource-centers/afib/good-results-with-catheter-ablation-in-afib Catheter ablation is recommended for those patients who have continuing symptoms despite taking medication. 3:13 PM, Fri January 20, 2017 Warfarin Nonadherence: What Factors Lead Patients with Afib to Discontinue? http://www.pharmacytimes.com/resource-centers/afib/warfarin-nonadherence-fibrillation Patients with atrial fibrillation (AF) frequently discontinue their warfarin therapy, and a recently-published study offers insight into factors that may contribute to nonadherence.<br /> &nbsp; 9:45 AM, Thu January 12, 2017 Bridging to Warfarin with Heparin in Atrial Fibrillation Isn't Necessary, May Be Harmful http://www.pharmacytimes.com/contributor/sean-kane-pharmd/2016/10/bridging-to-warfarin-with-heparin-in-atrial-fibrillation-isnt-necessary-may-be-harmful Little information exists regarding the benefit of bridging warfarin among patients with atrial fibrillation. The best available evidence suggests that this common practice may increase the risk of bleeding without providing any efficacy benefit. 12:34 AM, Mon October 10, 2016 More Patient Education Needed on Warfarin's Effects http://www.pharmacytimes.com/contributor/beth-bolt-rph/2016/09/more-patient-education-needed-on-warfarins-effects Recent study results suggest patients don’t know enough about warfarin, which could have potentially dangerous consequences. 11:08 PM, Thu September 8, 2016 Are NOACs Safe for Afib Patients with Worsening Renal Function? http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/08/are-noacs-safe-for-afib-patients-with-worsening-renal-function Although fixed daily doses of NOACs have demonstrated favorable efficacy and safety compared with warfarin, the impact of worsening renal function on these medications over time hasn’t been evaluated. 10:48 PM, Thu August 18, 2016 Should Afib Patients with Sepsis Receive Anticoagulation? http://www.pharmacytimes.com/contributor/douglas-jennings-pharmd-fccp-faha/2016/08/should-afib-patients-with-sepsis-receive-anticoagulation Sepsis leads to approximately 1 million hospitalizations in the United States yearly, and atrial fibrillation is the most common arrhythmia to complicate its course. 10:54 PM, Mon August 8, 2016 Black Patients Face Greater Risk for Poor Afib Outcomes http://www.pharmacytimes.com/resource-centers/afib/black-patients-face-greater-risk-for-poor-afib-outcomes Black patients with atrial fibrillation are more likely to experience stroke, heart failure, and coronary heart disease than their white counterparts. 10:45 PM, Wed June 29, 2016